Hydrocortisone
Rank #464 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$15.9M
Total Cost
762,398
Total Claims
$15.9M
Total Cost
25,955
Prescribers
$21
Cost per Claim
304,692
Beneficiaries
893,787
30-Day Fills
$613
Avg Cost/Provider
29
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$15.9M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $15.9M total
Top Prescribers of Hydrocortisone
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Hemlata Moturi | Endocrinology | Pittsburgh, PA | 443 | $30K |
| 2 | Peter Snyder | Internal Medicine | Philadelphia, PA | 260 | $21K |
| 3 | Eliza Geer | Endocrinology | New York, NY | 202 | $17K |
| 4 | Tina Josephson | Internal Medicine | Cherry Hill, NJ | 15 | $15K |
| 5 | Stephanie Romeis | Nurse Practitioner | Milwaukee, WI | 196 | $14K |
| 6 | Yousef Altowaireb | Endocrinology | Evansville, IN | 305 | $14K |
| 7 | Henry Lindner | Internal Medicine | Tunkhannock, PA | 150 | $14K |
| 8 | Sergei Chekov | Internal Medicine | Philadelphia, PA | 542 | $14K |
| 9 | William Amess | Endocrinology | Sacramento, CA | 126 | $14K |
| 10 | Jessica Brzana | Endocrinology | Issaquah, WA | 214 | $13K |
| 11 | Oleg Volchonok | Gastroenterology | Philadelphia, PA | 485 | $13K |
| 12 | Nydia Serrano | Podiatry | Orlando, FL | 12 | $13K |
| 13 | Nathan Pomeroy | Endocrinology | Grand Rapids, MI | 186 | $13K |
| 14 | Julia Kharlip | Endocrinology | Philadelphia, PA | 209 | $13K |
| 15 | Diana Maas | Endocrinology | Milwaukee, WI | 213 | $13K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 461 | Fluphenazine Hcl (Fluphenazine Hcl) | $16.0M | 73,051 |
| 462 | Nivolumab (Opdivo) | $16.0M | 1,275 |
| 463 | Leflunomide (Leflunomide) | $16.0M | 205,765 |
| 464 | Hydrocortisone (Hydrocortisone) | $15.9M | 762,398 |
| 465 | Digoxin (Digoxin) | $15.9M | 548,410 |
| 466 | Alpelisib (Piqray) | $15.7M | 747 |
| 467 | Doxazosin Mesylate (Doxazosin Mesylate) | $15.7M | 729,878 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology